Concepedia

Ravi P. Shaliwal

RP

Statistics

Publications

2

Citations

51

H-Index

2

Active since

2020

Affiliations

Translational Health Science and Technology Institute(Current)

Ravi P. Shaliwal is an author at Translational Health Science and Technology Institute specializing in drug discovery, tuberculosis drug development, and mycobacterium tuberculosis infection.

Publications per year

2020–2020

2

Publications

2

NSC 18725, a Pyrazole Derivative Inhibits Growth of Intracellular Mycobacterium tuberculosis by Induction of Autophagy

Garima Arora, Gagandeep, Assirbad Behura et al. · Frontiers in Microbiology · 2020 · 28 citations · Full text

, , +13

Synthesis and evaluation of thiophene based small molecules as potent inhibitors of Mycobacterium tuberculosis

Chhuttan L. Meena, Padam Singh, Ravi P. Shaliwal et al. · European Journal of Medicinal Chemistry · 2020 · 23 citations

, , +15

1–2 of 2